Y. Moriyama et al., ABSORPTION CHARACTERISTICS OF AZASETRON FROM RECTAL AND ORAL ROUTES IN RABBITS, Biological & pharmaceutical bulletin, 20(6), 1997, pp. 701-703
The absorption characteristics of azasetron, a serotonin type 3 (5-HT3
) receptor antagonist which is used for the treatment of chemotherapy-
induced emesis and nausea, were investigated in rabbits. The serum con
centrations of azasetron following rectal administration as a supposit
ory increased rapidly and showed the mean t(max) value of 0.18 h. The
concentrations were greater after rectal administration than those aft
er oral administration. The absolute bioavailability was significantly
different between the rectal, 52.9% and oral doses, 21.6%. The mean C
-max and t(max) values after the rectal dose were 904.8 ng/ml and 0.18
h, respectively, whereas those after the oral dose averaged 224.7 ng/
ml and 0.85 h, respectively. These results indicate that azasetron is
absorbed to a greater extent and more rapidly into the systemic circul
ation via the rectum than via the intestine in rabbits. Consequently,
the suppository form of azasetron hydrochloride may be feasible for th
e treatment of chemotherapy-induced acute emesis and nausea.